| The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial 2020 · hesperidin · Patients with metabolic syndrome; age and sex not specified | 1 g | 12 weeks | — |
| Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial 2021 · hesperidin group · Adults with metabolic syndrome; age and sex not specified | 1 g | 12 weeks | — |
| Effect of Pycnogenol on the Healing of Venous Ulcers 2017 · Group 2 · Adults with venous ulcers | 100 mg | 90 days | 15 |
| Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial 2021 · combination group · Adults with metabolic syndrome; age and sex not specified | 1 g | 12 weeks | — |
| The effect of citrus flavonoid extract supplementation on anaerobic capacity in moderately trained athletes: a randomized controlled trial 2021 · CFE500 · Healthy, moderately trained men and women aged 18–35 years | 500 mg | 8 weeks | 31 |
| The effect of citrus flavonoid extract supplementation on anaerobic capacity in moderately trained athletes: a randomized controlled trial 2021 · CFE400 · Healthy, moderately trained men and women aged 18–35 years | 400 mg | 8 weeks | 30 |
| Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome 2011 · hesperidin treatment period · Individuals with metabolic syndrome | 500 mg | 3 weeks | 24 |
| 8 weeks of 2S-Hesperidin supplementation improves muscle mass and reduces fat in amateur competitive cyclists: randomized controlled trial 2021 · 2S-hesperidin · Amateur competitive cyclists; age and sex not specified | 500 mg | 8 weeks | 20 |
| Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial 2016 · GH · Japanese men and women aged 20–65 years with BMI 24–30 kg/m² and serum triglycerides 100–250 mg/dL | 500 mg | 12 weeks | 15 |
| Acute Effects of Hesperidin in Oxidant/Antioxidant State Markers and Performance in Amateur Cyclists 2019 · Cardiose® (2S-hesperidin) · Healthy male amateur cyclists aged 18–50 years | 500 mg | 1 day | 15 |
| Effects of alpha-glucosylhesperidin, a bioactive food material, on collagen-induced arthritis in mice and rheumatoid arthritis in humans 2008 · Hsp-G group · Patients with rheumatoid arthritis | 3 g | 12 weeks | 9 |
| Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals 2016 · hesperidin 2S · Overweight individuals; age and sex not specified | 450 mg | 6 weeks | — |
| The Effect of Hesperidin and Diosmin Individually or in Combination on Metabolic Profile and Neuropathy among Diabetic Patients with Metabolic Syndrome: A Randomized Controlled Trial 2023 · hesperidin · Adults with type 2 diabetes, metabolic syndrome, and diabetic neuropathy | 1 g | 12 weeks | — |
| Evaluation of a preemptive intervention regimen with hesperidin methyl chalcone in delayed-onset muscle soreness in young adults: a randomized, double-blinded, and placebo-controlled trial study 2023 · HMC · Sedentary young men; age range and health condition beyond being sedentary were not specified | 500 mg | 3 days | — |
| The Effect of a Citrus and Pomegranate Complex on Physical Fitness and Mental Well-Being in Healthy Elderly: A Randomized Placebo-Controlled Trial 2022 · Citrus and pomegranate complex (CPC) · Healthy adults aged 60–75 years, with BMI 18–28 kg/m² | 450 mg | 4 weeks | 36 |
| The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial 2021 · GT-gH group · Healthy Japanese men and women aged 30–75 years with BMI 23–30 kg/m² and LDL cholesterol 100–140 mg/dL; not regular green tea consumers | 178 mg | 12 weeks | 30 |
| Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease 2015 · Hesperidin supplement · Men aged 51–69 years, healthy non-smokers at moderate cardiovascular disease risk | 320 mg | 1 day | 15 |
| Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial 2016 · GH + Caf 25 · Japanese men and women aged 20–65 years with BMI 24–30 kg/m² and serum triglycerides 100–250 mg/dL | 500 mg | 12 weeks | 15 |
| Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial 2016 · GH + Caf 50 · Japanese men and women aged 20–65 years with BMI 24–30 kg/m² and serum triglycerides 100–250 mg/dL | 500 mg | 12 weeks | 15 |
| Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial 2016 · GH + Caf 75 · Japanese men and women aged 20–65 years with BMI 24–30 kg/m² and serum triglycerides 100–250 mg/dL | 500 mg | 12 weeks | 15 |
| Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes 2011 · Group 4: Advantra Z with 100 mg hesperidin and 600 mg naringin · Healthy human subjects; age range and sex not reported | 100 mg | 1 day | 10 |
| Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes 2011 · Group 5: Advantra Z with 1,000 mg hesperidin and 600 mg naringin · Healthy human subjects; age range and sex not reported | 1 g | 1 day | 10 |
| The Effect of Hesperidin and Diosmin Individually or in Combination on Metabolic Profile and Neuropathy among Diabetic Patients with Metabolic Syndrome: A Randomized Controlled Trial 2023 · combination of hesperidin and diosmin · Adults with type 2 diabetes, metabolic syndrome, and diabetic neuropathy | 1 g | 12 weeks | — |
| Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin 1994 · Daflon 500 mg group · Patients with chronic venous insufficiency of the lower limbs, stabilized for one year; age and sex not reported | 100 mg | 60 days | — |
| Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study) 2021 · OJ · Adults aged 18–65 with pre- or stage-1 hypertension | 345 mg | 12 weeks | 53 |
| Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study) 2021 · EOJ · Adults aged 18–65 with pre- or stage-1 hypertension | 600 mg | 12 weeks | 53 |
| Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial 2018 · hesperidin group · Adults with type 2 diabetes; age and sex not specified | 500 mg | 6 weeks | — |
| Hesperidin Bioavailability Is Increased by the Presence of 2S-Diastereoisomer and Micronization-A Randomized, Crossover and Double-Blind Clinical Trial 2022 · Hesperidin epimeric mixture (HEM) · Healthy men and women aged 18 years or older, selected as intermediate hesperidin metabolite excretors | 250 mg | 1 day | 14 |
| Hesperidin Bioavailability Is Increased by the Presence of 2S-Diastereoisomer and Micronization-A Randomized, Crossover and Double-Blind Clinical Trial 2022 · Micronized Hesperidin epimeric mixture (MHEM) · Healthy men and women aged 18 years or older, selected as intermediate hesperidin metabolite excretors | 250 mg | 1 day | 14 |
| Hesperidin Bioavailability Is Increased by the Presence of 2S-Diastereoisomer and Micronization-A Randomized, Crossover and Double-Blind Clinical Trial 2022 · Micronized 2S-Hesperidin (M2SH) · Healthy men and women aged 18 years or older, selected as intermediate hesperidin metabolite excretors | 250 mg | 1 day | 14 |
| 8 weeks of 2S-hesperidin prevents a decrease in pO(2) at submaximal intensity in amateur cyclists in off-season: randomized controlled trial 2023 · 2S-hesperidin · Amateur cyclists in an off-season period; age and sex not stated | 500 mg | 8 weeks | 20 |
| Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study 2011 · control drink + hesperidin · Healthy, moderately overweight men aged 50–65 years without chronic disease | 292 mg | 4 weeks | 10 |
| Hesperidin supplementation modulates inflammatory responses following myocardial infarction 2015 · hesperidin group · Patients with myocardial infarction; age and sex not specified | 600 mg | 4 weeks | — |
| Hesperidin Supplementation Alleviates Oxidative DNA Damage and Lipid Peroxidation in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial 2017 · hesperidin group · patients with type 2 diabetes; age and sex not reported | 500 mg | 6 weeks | — |
| The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial 2021 · lifestyle modification program with 1 g hesperidin supplementation · Patients with non-alcoholic fatty liver disease; age and sex not specified | 1 g | 12 weeks | — |
| The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial 2021 · lifestyle modification program with combination of 30 g flaxseed and 1 g hesperidin (flax-hes) · Patients with non-alcoholic fatty liver disease; age and sex not specified | 1 g | 12 weeks | — |
| Concomitant use of tea catechins affects absorption and serum triglyceride-lowering effects of monoglucosyl hesperidin 2021 · Study 2: GHES and GTC beverage · healthy men and women, mean age 53 ± 2 years | 165 mg | 4 weeks | — |
| A Citrus and Pomegranate Complex Reduces Methylglyoxal in Healthy Elderly Subjects: Secondary Analysis of a Double-Blind Randomized Cross-Over Clinical Trial 2023 · Citrus and pomegranate complex treatment · Healthy, non-smoking adults aged 60–75 years | 450 mg | 4 weeks | — |